ppharmПедиатрическая фармакологияPediatric pharmacology1727-57762500-3089Издательство «ПедиатрЪ»10.15690/pf.v11i1.892ppharm-136Research ArticleЛЕКЦИЯLECTUREТЕРАПИЯ ОСТРЫХ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ У ДЕТЕЙ: ЧТО НОВОГО?THERAPY OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN: NOVELTIESЗахароваИ. Н.ZakharovaI. N.

доктор медицинских наук, профессор, заведующая кафедрой педиатрии ГБОУ ДПО «РМАПО» МЗ РФ, заслуженный врач Российской Федерации

PhD, Professor, head of the department of pediatrics of the Russian Medical Academy of Postgraduate Education (State Budgetary Educational Institution) of the RF MH (Ministry of Health), Honored Doctor of the Russian Federation

kafedra25@yandex.ruГоряйноваА. Н.GoryaynovaA. N.КороидН. В.KoroidN. V.ТоршхоеваЛ. Б.TorshkhoyevaL. B.ЛагадзеИ. Б.LagadzeI. B.Российская медицинская академия последипломного образования МЗ РФ, МоскваРоссияRussian Medical Academy of Postgraduate Education of the RF MH (Ministry of Health), MoscowRussian FederationРоссийская медицинская академия последипломного образования МЗ РФ, МоскваРоссияRussian Medical Postgraduate Academy of the RF MH (Ministry of Health), MoscowRussian FederationТушинская детская городская больница города Москвы, Российская ФедерацияРоссияTushino Children’s Municipal Hospital of Moscow, Russian FederationRussian Federation201415022014111Педиатрическая фармакология3136Copyright © Захарова И.Н., Горяйнова А.Н., Короид Н.В., Торшхоева Л.Б., Лагадзе И.Б., 20142014Захарова И.Н., Горяйнова А.Н., Короид Н.В., Торшхоева Л.Б., Лагадзе И.Б.Zakharova I.N., Goryaynova A.N., Koroid N.V., Torshkhoyeva L.B., Lagadze I.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pedpharma.ru/jour/article/view/136

The article is dedicated to acute respiratory infections — the most frequent cause of visits to doctors all around the world, especially among children under 5 years of age. The authors cite data on clinical ARI course variants in small children, present data of virologic analysis and immune status peculiarities, list the main methods of ARI prevention in children and assess efficacy of using bacterial lysates in children with acute and recurrent acute respiratory diseases.

 

острые респираторные инфекцииэтиологияклиническое течениеиммунная системавирусыбактериииммуностимуляторыбактериальные лизатыдетиacute respiratory infectionsetiologyclinical courseimmune systemvirusesbacteriaimmunostimulantsbacterial lysateschildrenReferencesGaribaldi R. A. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am J Med. 1985 Jun 28;78 (6B): 32–7.Garibaldi R. A. Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact. Am. J. Med. 1985 Jun 28;78 (6B): 32–37.Fendrick A. M., Monto A. S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003 Feb 24; 163 (4): 487–94.Fendrick A. M., Monto A. S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Intern. Med. 2003 Feb 24; 163 (4): 487–494.Захарова И. Н., Чебуркин А. В., Малиновская В. В. и соавт. Значение системы интерферонов в формировании иммунного ответа у детей с острыми респираторными вирусными инфекциями. Вопросы практической педиатрии. 2009; 4 (5): 38–45.Zakharova I.N., Cheburkin A.V., Malinovskaya V.V. et al. Importance of interferon system for immune response formation in children with acute respiratory viral infections. Voprosy prakticheskoi pediatrii = Problems of practical pediatrics. 2009; 4 (5): 38–45.Захарова И. Н., Малиновская В. В., Торшхоева Л. Б. Клинико-иммунологическая эффективность применения препарата на основе рекомбинантного IFN-А2 Виферон (суппозитории и мазь) при лечении острых респираторных инфекций у детей раннего возраста. Педиатрия. 2011; 4: 28.Zakharova I. N., Malinovskaya V. V., Torshkhoeva L. B. Clinical-immunological efficacy of using a drug based on recombinant IFN-A2 Viferon (suppositories and ointment) for treating acute respiratory infections in small children. Pediatriya = Pediatrics. 2011; 4: 28.Захарова И. Н., Малиновская В. В., Коровина Н. А. и соавт. Клинико-иммунологическое обоснование местной интерферонотерапии при респираторных вирусных инфекциях у детей. Вопросы практической педиатрии. 2011; 6 (5): 21–26.Zakharova I.N., Malinovskaya V.V., Korovina N.A. et al. Clinical-immunological substantiation of local interferon therapy for respiratory viral infections in children. Voprosy prakticheskoi pediatrii = Problems of practical pediatrics.2011; 6 (5): 21–26.Захарова И. Н., Торшхоева Л. Б., Заплатников А. Л. и соавт. Особенности системы интерферона при острых респираторных инфекциях и клинико-иммунологическая эффективность модифицированной интерферонотерапии у детей раннего возраста. Эффективная фармакотерапия. Педиатрия. 2011; 1: 70.Zakharova I.N., Torshkhoeva L.B., Zaplatnikov A.L. et al. Interferon system peculiarities at acute respiratory infections and clinical-immunological efficacy of modified interferon therapy in small children. Efficient pharmacotherapy. Pediatriya = Pediatrics. 2011; 1: 70.Захарова И. Н., Торшхоева Л. Б., Заплатников А. Л. и соавт. Модифицированная интерферонотерапия острых респираторных инфекций у детей раннего возраста: патогенетическое обо-снование и эффективность. Российский вестник перинатологии и педиатрии. 2011; 56 (3): 49–54.Zakharova I.N., Torshkhoeva L.B., Zaplatnikov A.L. et al. Modified interferon therapy for acute respiratory infections in small children: pathogenetic substantiation and efficacy. Rossiiskii vestnik perinatologii i pediatrii = Russian bulletin of perinatology and pediatrics. 2011; 56 (3): 49–54.Nelson Essentials of Pediatrics (6th ed.). 2011. 831 p.Nelson Essentials of Pediatrics (6th ed.). 2011. 831 p.Малиновская В. В., Захарова И. Н., Исаева Е. И. и соавт. Этиологическая структура острых респираторных инфекций у детей раннего возраста. Вопросы практической педиатрии. 2010; 5 (5): 99–104.Malinovskaya V.V., Zakharova I.N., Isaeva E.I. et al. Etiological structure of acute respiratory infections in small children. Voprosy prakticheskoi pediatrii = Problems of practical pediatrics. 2010; 5 (5): 99–104.Ботвиньева В. В., Арефьева Н. А., Азнабаева Л. Ф., Иванова Р. А., Романцов М. Г. Респираторные заболевания: этиопатогенез, клиника, лечение, профилактика. Руководство для врачей. СПб. 2002. 48 с.Botvin'eva V.V., Aref'eva N.A., Aznabaeva L.F., Ivanova R.A., Romantsov M.G. Respiratornye zabolevaniya: etiopatogenez, klinika, lechenie, profilaktika. Rukovodstvo dlya vrachei [Respiratory Diseases: Etiopathogenesis, Clinical Pattern, Treatment, Prevention. Guidelines]. St. Petersburg, 2002. 48 p.Швец Е. Ю. Клинико-эпидемиологические особенности и диагностика бокавирусной инфекции у детей. Автореф. дис. … канд. мед. наук. М., 2009. 24 с.Shvets E.Yu. Kliniko-epidemiologicheskie osobennosti i diagnostika bokavirusnoi infektsii u detei. Avtoref. dis. … kand. med. nauk [Clinical and Epidemiological Peculiarities and Bocavirus Infection Diagnostics in Children. Author’s abstract]. Moscow, 2009. 24 p.Козулина И. С., Самсыгина Г. А., Исаева Е. И., Легкова Т. П., Шевченко И. М., Донин И. М., Павлов С. А. Метапневмовирусная инфекция у детей. Педиатрия. 2009; 88 (5): 58–62.Kozulina I.S., Samsygina G.A., Isaeva E.I., Legkova T.P., Shevchenko I.M., Donin I.M., Pavlov S.A. Metapneumovirus infection in children. Pediatriya = Pediatrics. 2009; 88 (5): 58–62.Braido F., Tarantini F., Ghiglione V., Melioli G., Canonica G.W. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. International Journal of COPD. 2007; 2 (3): 335–345.Braido F., Tarantini F., Ghiglione V., Melioli G., Canonica G.W. Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections. International Journal of COPD. 2007; 2 (3): 335–345.Sramek J., Josifko M., Helcl J., Holoubkova E., Janout V., Kozesnik B., Macatova I. Bacterial lysate (I.R.S. 19) applied intranasally in the prevention of acute respiratory diseases in children: a randomized double-blind study. J Hyg Epidemiol Microbiol Immunol. 1986; 30 (4): 377–85.Sramek J., Josifko M., Helcl J., Holoubkova E., Janout V., Kozesnik B., Macatova I. Bacterial lysate (I.R.S. 19) applied intranasally in the prevention of acute respiratory diseases in children: a randomized double-blind study. J. Hyg. Epidemiol. Microbiol. Immunol. 1986; 30 (4): 377–385.Binder P., Gendre F., Huart B., Paucod J.C., Deschaux P., Fontan ges R. Immunomodulation in offspring mice after neonatal immunostimulation of mothers or newborn mice. Tohoku J Exp Med. 1985 Aug; 146 (4): 379–83.Binder P., Gendre F., Huart B., Paucod J.C., Deschaux P., Fontan ges R. Immunomodulation in offspring mice after neonatal immunostimulation of mothers or newborn mice. Tohoku J. Exp. Med. 1985 Aug; 146 (4): 379–383.Razi C., Harmanci K., Abaci A., Ozdemir O., Hizli S., Renda R., Keskin F. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010; 126: 763–9.Razi C., Harmanci K., Abaci A., Ozdemir O., Hizli S., Renda R., Keskin F. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J. Allergy Clin. Immunol. 2010; 126: 763–769.Schaad U., Mutterlein R., Goffin H. BV-child study group. Immunostimulation with OM-85 in children with acute recurrent infections of the upper respiratory tract. Chest. 2002; 122: 2042–9.Schaad U., Mutterlein R., Goffin H. BV-child study group. Immunostimulation with OM-85 in children with acute recurrent infections of the upper respiratory tract. Chest. 2002; 122: 2042–2049.Gutierrez-Tarango M., Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest. 2001; 119: 1742–8.Gutierrez-Tarango M., Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest. 2001; 119: 1742–1748.Schaad U. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur Respir Rev. 2005; 14: 74–7.Schaad U. Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85. Eur. Respir. Rev. 2005; 14: 74–77.Maestroni G., Losa G. Clinical and immunobiological effects of an orally administered bacterial extract. Int J Immunopharmacol. 1984; 6: 111–7.Maestroni G., Losa G. Clinical and immunobiological effects of an orally administered bacterial extract. Int. J. Immunopharmacol. 1984; 6: 111–117.Berber A., Del-Rio-Navarro B. Use of Broncho-Vaxom in private practice: phase IV trial in 587 children. Clin Ther. 1996 Nov-Dec; 18 (6): 1068–79.Berber A., Del-Rio-Navarro B. Use of Broncho-Vaxom in private practice: phase IV trial in 587 children. Clin. Ther. 1996 Nov-Dec; 18 (6): 1068–1079.Emmerich B., Emslander H., Milatovic D., Hallek M., Pachmann K. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis. Respiration. 1990; 57 (2): 90–9.Emmerich B., Emslander H., Milatovic D., Hallek M., Pachmann K. Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis. Respiration. 1990; 57 (2): 90–99.Soler M., Mutterlein R., Cozma G. Double-Blind Study of OM-85 in Patients with Chronic Bronchitis or Mild Chronic Obstructive Pulmonary Disease. Respiration. 2007; 74: 26–32.Soler M., Mutterlein R., Cozma G. Double-Blind Study of OM-85 in Patients with Chronic Bronchitis or Mild Chronic Obstructive Pulmonary Disease. Respiration. 2007; 74: 26–32.Carmona-Ramirez M., Alvarez-Gomez V., Berber A. Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational Medicine. The Journal of International Medical Research. 2002; 30: 325–329.Carmona-Ramirez M., Alvarez-Gomez V., Berber A. Use of OM-85 BV for the Prevention of Acute Respiratory Tract Infections in Occupational Medicine. The Journal of International Medical Research. 2002; 30: 325–329.Navarro S., Cossalter G., Chiavaroli C., Kanda A., Fleury S., Lazzari A., Cazareth J., Sparwasser T., Dombrowicz D., Glaichenhaus N., Julia V. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunology. 2011; 4 (1): 53–65.Navarro S., Cossalter G., Chiavaroli C., Kanda A., Fleury S., Lazzari A., Cazareth J., Sparwasser T., Dombrowicz D., Glaichenhaus N., Julia V. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunology. 2011; 4 (1): 53–65.Steurer-Stey C., Bachmann L., Steurer J., Tramer M. R. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest. 2004 Nov; 126 (5): 1645–55.Steurer-Stey C., Bachmann L., Steurer J., Tramer M. R. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review. Chest. 2004 Nov; 126 (5): 1645–55.Jonston S., Pattermore P., Sanderson G., Smith S., Lampe F., Josephs S. et al. Role of virus infections in exacerbations in children with recurrent wheeze or cough. Thorax. 1993; 48: 1055.Jonston S., Pattermore P., Sanderson G., Smith S., Lampe F., Josephs S. et al. Role of virus infections in exacerbations in children with recurrent wheeze or cough. Thorax. 1993; 48: 1055.Jonston S., Pattermore P., Sanderson G., Smith S, Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A. et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995; 310: 1225–9.Jonston S., Pattermore P., Sanderson G., Smith S, Lampe F., Josephs L., Symington P., O'Toole S., Myint S.H., Tyrrell D.A. et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ. 1995; 310: 1225–9.Pessey J. J., Megas F., Arnould B., Baron-Papillon F. Prevention of recurrent rhinopharyngitis in at-risk children in France: a cost-effectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV). Pharmacoeconomics. 2003; 21 (14): 1053–68.Pessey J. J., Megas F., Arnould B., Baron-Papillon F. Prevention of recurrent rhinopharyngitis in at-risk children in France: a costeffectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV). Pharmacoeconomics. 2003; 21 (14): 1053–1068.

The authors declare that there are no conflicts of interest present.